Anti-inflammatory and Antinociceptive Activities of Azadirachtin in Mice

Abstract

Azadirachta indica (Meliaceae) extracts have been reported to exhibit anti-inflammatory and antinociceptive properties. However, the activities of azadirachtin, a limonoid and the major bioactive compound found in the extracts, have been poorly investigated in animal models. In the present study, we investigated the effects induced by azadirachtin in experimental models of pain and inflammation in mice. Carrageenan-induced paw edema and fibrovascular tissue growth induced by subcutaneous cotton pellet implantation were used to investigate the anti-inflammatory activity of azadirachtin in mice. Zymosan-induced writhing and hot plate tests were employed to evaluate the antinociceptive activity. To explore putative mechanisms of action, the level of tumor necrosis factor-α in inflammatory tissue was measured and the effect induced by opioidergic and serotonergic antagonists was evaluated. Previous per os (p. o.) administration of azadirachtin (120 mg/kg) significantly reduced the acute paw edema induced by carrageenan. However, the concomitant increase of the paw concentration of tumor necrosis factor-α induced by this inflammatory stimulus was not reduced by azadirachtin. In addition to inhibiting the acute paw edema induced by carrageenan, azadirachtin (6, 60, and 120 mg/kg) inhibited the proliferative phase of the inflammatory response, as demonstrated by the reduced formation of fibrovascular tissue growth. Azadirachtin (120 mg/kg) also inhibited the nociceptive response in models of nociceptive (hot plate) and inflammatory (writhing induced by zymosan) pain. The activity of azadirachtin (120 mg/kg) in the model of nociceptive pain was attenuated by a nonselective opioid antagonist, naltrexone (10 mg/kg, i. p.), but not by a nonselective serotonergic antagonist, cyproheptadine. In conclusion, this study demonstrates the activity of azadirachtin in experimental models of nociceptive and inflammatory pain, and also in models of acute and chronic inflammation. Finally, multiple mechanisms, including the inhibition of the production of inflammatory mediators and activation of endogenous opioid pathways, may mediate azadirachtin activities in experimental models of inflammation and pain.

Key words

Azadirachta indica A. Juss - Meliaceae - azadirachtin - inflammation - nociception - pain

• References

• 1 Calixto JB, Campos MM, Otuki MF, Santos ARS. Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med 2004; 70: 93-103
• 2 Calixto JB, Otuki MF, Santos ARS. Antiinflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor-κB (NF-κB). Planta Med 2003; 69: 973-983
• 3 Ríos JL, Recio MC, Escandell JM, Andújar I. Inhibition of transcription factors by plant-derived compounds and their implications in inflammation and cancer. Curr Pharm Des 2009; 15: 1212-1237
• 4 Atawodi SE, Atawodi JC. Azadirachta indica (neem): a plant of multiple biological and pharmacological activities. Phytochem Rev 2009; 8: 601-620
• 5 Biswas K, Chattopadhyay I, Banerjee RK, Bandyopadhyay U. Biological activities and medicinal properties of neem (Azadirachta indica). Curr Sci 2002; 82: 1336-1345
• 6 Morgan ED. Azadirachtin, a scientific gold mine. Bioorg Med Chem 2009; 17: 4096-4105
• 7 Sidhu OP, Kumar V, Behl HM. Variability in neem (Azadirachta indica) with respect to azadirachtin content. J Agric Food Chem 2003; 51: 910-915
• 8 Mosaddek AS, Rashid MU. A comparative study of the anti-inflammatory effect of aqueous extract of neem leaf and dexamethasone. Bangladesh J Pharmacol 2008; 3: 44-47
• 9 Subapriya K, Nagini S. Medicinal properties of neem leave: a review. Curr Med Chem 2005; 5: 149-156
• 10 Okpanyi SN, Ezeukwu GC. Anti-inflammatory and antipyretic activities of Azadirachta indica . Planta Med 1981; 41: 34-39
• 11 Chattopadhyay RR. Possible biochemical mode of anti-inflammatory action of Azadirachta indica A. Juss. in rats. Indian J Exp Biol 1998; 36: 418-420
• 12 Khosla P, Bhanwra S, Singh J, Srivastava RK. Antinociceptive activity of Azadirachta indica (neem) in rats. Indian J Pharmacol 2000; 32: 372-374
• 13 Ashorobi RB. Antipyretic effect of Azadirachta indica in bacteria endotoxin induced fever in the rat. Phytother Res 1998; 12: 41-43
• 14 Schumacher M, Cerella C, Reuter S, Dicato M, Diederich M. Anti-inflammatory, pro-apoptotic, and anti-proliferative effects of a methanolic neem (Azadirachta indica) leaf extract are mediated via modulation of the nuclear factor-κB pathway. Genes Nutr 2011; 6: 149-160
• 15 Valério DA, Cunha TM, Arakawa NS, Lemos HP, Da Costa FB, Parada CA, Ferreira SH, Cunha FQ, Verri jr. WA. Anti-inflammatory and analgesic effects of the sesquiterpene lactone budlein A in mice: inhibition of cytokine production-dependent mechanism. Eur J Pharmacol 2007; 562: 155-163
• 16 Raizada RB, Srivastava MK, Kaushal RA, Singh RP. Azadirachtin, a neem biopesticide: subchronic toxicity assessment in rats. Food Chem Toxicol 2001; 39: 477-483
• 17 Rocha AC, Fernandes ES, Quintão NL, Campos MM, Calixto JB. Relevance of tumour necrosis factor-alpha for the inflammatory and nociceptive responses evoked by carrageenan in the mouse paw. Br J Pharmacol 2006; 148: 688-695
• 18 Moore AR, Greenslade KJ, Alam CA, Willoughby DA. Effects of diacerhein on granuloma induced cartilage breakdown in the mouse. Osteoarthr Cartil 1998; 6: 19-23
• 19 Lukacs NW, Chensue SW, Smith RE, Strieter RM, Warmington K, Wilke C, Kunkel SL. Production of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 alpha by inflammatory granuloma fibroblasts. Am J Pathol 1994; 144: 711-718
• 20 Kamei D, Yamakawa K, Takegoshi Y, Mikami-Nakanishi M, Nakatani Y, Oh-Ishi S, Yasui H, Azuma Y, Hirasawa N, Ohuchi K, Kawaguchi H, Ishikawa Y, Ishii T, Uematsu S, Akira S, Murakami M, Kudo I. Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin E synthase-1. J Biol Chem 2004; 279: 33684-33695
• 21 Thoh M, Kumar P, Nagarajaram HA, Manna SK. Azadirachtin interacts with the tumor necrosis factor (TNF) binding domain of its receptors and inhibits TNF-induced biological responses. J Biol Chem 2010; 285: 5888-5895
• 22 Ghosh S, Karin M. Missing pieces in the NF-κB puzzle. Cell 2002; 109: S81-S96
• 23 Lawrence T. The nuclear factor NF-κB pathway in inflammation. Cold Spring Harb Perspect Biol 2009; 1: a001651
• 24 Ribeiro RA, Vale ML, Thomazzi SM, Paschoalato AB, Poole S, Ferreira SH, Cunha FQ. Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol 2000; 387: 111-118
• 25 Vriens J, Owsianik G, Hofmann T, Philipp SE, Stab J, Chen X, Benoit M, Xue F, Janssens A, Kerselaers S, Oberwinkler J, Vennekens R, Gudermann T, Nilius B, Voets T. TRPM3 is a nociceptor channel involved in the detection of noxious heat. Neuron 2011; 70: 482-494
• 26 Engelhardt G, Homma D, Schlegel K, Utzmann R, Schnitzler C. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance. Inflamm Res 1995; 44: 423-433
• 27 Duman EN, Kesim M, Kadioglu M, Yaris E, Kalyoncu NI, Erciyes N. Possible involvement of opioidergic and serotonergic mechanisms in antinociceptive effect of paroxetine in acute pain. J Pharmacol Sci 2004; 94: 161-165
• 28 Smith HS. Potential analgesic mechanisms of acetaminophen. Pain Physician 2009; 12: 269-280
• 29 Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109-110
• 30 Godin AM, Ferreira WC, Rocha LT, Seniuk JG, Paiva AL, Merlo LA, Nascimento jr. EB, Bastos LF, Coelho MM. Antinociceptive and anti-inflammatory activities of nicotinamide and its isomers in different experimental models. Pharmacol Biochem Behav 2011; 99: 782-788